智通财经APP讯，锦欣生殖(01951)发布公告，根据购回授权，本公司获准于香港联合交易所有限公司(联交所)购回最多2.74亿股股份，占于股东周年大会日期已发行股份(不包括库存股份)总数的10%。本公司认为，股份目前的交易价格并未反映其内在价值或本公司的实际业务前景。因此，本公司董事会(董事会)已议决利用购回授权，以不时在公开市场上按不少于1亿港元的总价格购回股份(建议股份购回)。本公司认为，建议股份购回将展现本公司对其自身业务发展前景充满信心，而本公司现有财务资源将足以支持实施建议股份购回，同时维持稳健的财务状况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.